E-LIB Suche - Ergebnisse für: Niglio, Scot A.

1

Pembrolizumab monotherapy for high-risk non-muscle-invasive..:

Necchi, Andrea ; Roumiguié, Mathieu ; Kamat, Ashish M...
The Lancet Oncology. 25 (2024) 6 - p. 720-730 , 2024

2

Safety and efficacy of immune checkpoint inhibitors in adva..:

El Zarif, Talal ; Nassar, Amin H ; Pond, Gregory R...
JNCI: Journal of the National Cancer Institute. 115 (2023) 12 - p. 1605-1615 , 2023

Link: https://doi.org/10.1093/..

3

Cabozantinib plus Nivolumab Phase I Expansion Study in Pati..:

Girardi, Daniel M. ; Niglio, Scot A. ; Mortazavi, Amir...
Clinical Cancer Research. 28 (2022) 7 - p. 1353-1362 , 2022

Link: https://doi.org/10.1158/..

4

Clinical value of 18FDG PET/MRI in muscle-invasive, locally..:

Civelek, Ali Cahid ; Niglio, Scot A. ; Malayeri, Ashkan A....
Urologic Oncology: Seminars and Original Investigations. 39 (2021) 11 - p. 787.e17-787.e21 , 2021

Link: https://doi.org/10.1016/..

5

Novel Therapies:

, In: Bladder Cancer,

Niglio, Scot ; Galsky, Matthew D. - p. 315-322 , 2021

Link: https://doi.org/10.1007/..

6

A Rare Presentation of HIV-Negative Plasmablastic Lymphoma:..:

Kessler, Alaina J. ; Marcellino, Bridget K. ; Niglio, Scot A...
Case Reports in Hematology. 2019 (2019) - p. 1-4 , 2019

Link: https://doi.org/10.1155/..

7

Programmed Death-1 or Programmed Death Ligand-1 Blockade in..:

Niglio, Scot A. ; Jia, Rachel ; Ji, Jiayi...
European Urology. 76 (2019) 6 - p. 782-789 , 2019

Link: https://doi.org/10.1016/..

8

Early Mortality in Patients With Muscle-Invasive Bladder Ca..:

Marqueen, Kathryn E ; Waingankar, Nikhil ; Sfakianos, John P...
JNCI Cancer Spectrum. 2 (2018) 4 - p. , 2018

Link: https://doi.org/10.1093/..

9

Targeting Glutamatergic Signaling and the PI3 Kinase Pathwa..:

Rosenberg, Stephen A. ; Niglio, Scot A. ; Salehomoum, Negar...
Translational Oncology. 8 (2015) 1 - p. 1-9 , 2015

Link: https://doi.org/10.1016/..

10

Interdigitating Dendritic Cell Sarcoma Presenting in the Sk..:

Rosenberg, Stephen A. ; Niglio, Scot A. ; Jo, Vickie Y..
Rare Tumors. 6 (2014) 4 - p. 135-137 , 2014

Link: https://doi.org/10.4081/..

11

Cabozantinib plus Nivolumab Phase I Expansion Study in Pati..:

Girardi, Daniel M ; Niglio, Scot A ; Mortazavi, Amir...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365339/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Clinical value of (18)FDG PET/MRI in muscle-invasive, local..:

Civelek, Ali Cahid ; Niglio, Scot A ; Malayeri, Ashkan A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211471/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Circulating Tumor Cell Subtypes and T-cell Population as Pr..:

Chalfin, Heather ; Pramparo, Tiziano ; Mortazavi, Amir...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925349/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Phase I Study of Cabozantinib and Nivolumab Alone or With I..:

Apolo, Andrea B ; Nadal, Rosa ; Girardi, Daniel M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605393/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Precision Medicine for Relapsed Multiple Myeloma on the Bas..:

Laganà, Alessandro ; Beno, Itai ; Melnekoff, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350920/. , 2018

Link: http://www.ncbi.nlm.nih...